Related references
Note: Only part of the references are listed.Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy
Drew A. Spencer et al.
CURRENT CANCER DRUG TARGETS (2017)
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
Laura Garros-Regulez et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
High-Throughput Chemical Screens Identify Disulfiram as an Inhibitor of Human Glioblastoma Stem Cells
Parvinder Hothi et al.
Oncotarget (2015)
Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines
Maryam Rahman et al.
ANATOMY & CELL BIOLOGY (2015)
Three-dimensional in vitro tumor models for cancer research and drug evaluation
Xian Xu et al.
BIOTECHNOLOGY ADVANCES (2014)
Epidemiologic and Molecular Prognostic Review of Glioblastoma
Jigisha P. Thakkar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
Mario L. Suva et al.
CELL (2014)
Targeting Self-Renewal in High-Grade Brain Tumors Leads to Loss of Brain Tumor Stem Cells and Prolonged Survival
Zhe Zhu et al.
CELL STEM CELL (2014)
Cell surface Nestin is a biomarker for glioma stem cells
Xiong Jin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties
Mathieu Bibian et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Albert Lai et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
Steven M. Pollard et al.
CELL STEM CELL (2009)
SOX2 Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
Rosaria Maria Rita Gangemi et al.
STEM CELLS (2009)
3-D Tissue Culture Systems for the Evaluation and Optimization of Nanoparticle-Based Drug Carriers
Thomas Tyrel Goodman et al.
BIOCONJUGATE CHEMISTRY (2008)
Chemoresistance in gliomas
Chen Lu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme
C Giannini et al.
NEURO-ONCOLOGY (2005)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Molecular mechanisms of glioma cell migration and invasion
T Demuth et al.
JOURNAL OF NEURO-ONCOLOGY (2004)